Skip to main content

Peer Review reports

From: A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia

Original Submission
26 Apr 2018 Submitted Original manuscript
3 May 2018 Author responded Author comments - Haridas Upadya
Resubmission - Version 2
3 May 2018 Submitted Manuscript version 2
24 May 2018 Reviewed Reviewer Report - FATEMEH Heydarpour
31 May 2018 Reviewed Reviewer Report - Tarun Belwal
17 Jul 2018 Author responded Author comments - Haridas Upadya
Resubmission - Version 3
17 Jul 2018 Submitted Manuscript version 3
24 Jul 2018 Author responded Author comments - Haridas Upadya
Resubmission - Version 4
24 Jul 2018 Submitted Manuscript version 4
27 Aug 2018 Reviewed Reviewer Report - Tarun Belwal
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
8 Jan 2019 Editorially accepted
22 Jan 2019 Article published 10.1186/s12906-019-2430-y

You can find further information about peer review here.

Back to article page